Sorafenib analogue SC‐60 induces apoptosis through the SHP‐1/STAT3 pathway and enhances docetaxel cytotoxicity in triple‐negative breast cancer cells

Recurrent triple‐negative breast cancer (TNBC) needs new therapeutic targets. Src homology region 2 domain‐containing phosphatase‐1 (SHP‐1) can act as a tumor suppressor by dephosphorylating oncogenic kinases. One major target of SHP‐1 is STAT3, which is highly activated in TNBC. In this study, we t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chun‐Yu, Su, Jung‐Chen, Huang, Tzu‐Ting, Chu, Pei‐Yi, Huang, Chun‐Teng, Wang, Wan‐Lun, Lee, Chia‐Han, Lau, Ka‐Yi, Tsai, Wen‐Chun, Yang, Hsiu‐Ping, Shiau, Chung‐Wai, Tseng, Ling‐Ming, Chen, Kuen‐Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527447/
https://www.ncbi.nlm.nih.gov/pubmed/28084011
http://dx.doi.org/10.1002/1878-0261.12033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527447/
https://www.ncbi.nlm.nih.gov/pubmed/28084011
http://dx.doi.org/10.1002/1878-0261.12033

Ejemplares similares